Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation

NCT00964106 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Interactions

Interventions

DRUG: Caffeine
DRUG: Rosiglitazone
DRUG: Flurbiprofen
DRUG: Omeprazole
DRUG: Dextromethorphan
DRUG: Midazolam
DRUG: Rosuvastatin
DRUG: Ketoconazole
DRUG: Fluconazole
DRUG: Rifampin
DRUG: Rosiglitazone

Sponsor

GlaxoSmithKline